LB2307. Safety and Efficacy of Letermovir (LET) Versus Valganciclovir (VGCV) for Prevention of Cytomegalovirus (CMV) Disease in Kidney Transplant Recipients (ktrs): A Phase 3 Randomized Study

Open forum infectious diseases(2022)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要